Alphabet Inc.
Position in BBOT — BridgeBio Oncology Therapeutics, Inc.
CIK 1652044
Mountain View, CA
Position in BBOT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$21,512,220
-$3,754,757 QoQ
Shares Held
2,823,126
0.0% QoQ
Ownership
3.52%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#4
of 66 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BBOT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Alphabet Inc. holds $884,358,161 across 13 Biotechnology names. BBOT ranks #6 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,946,619 | $551,842,806 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
|
4,919,498 | $134,646,660 | |
| 3 | PRME |
Prime Medicine, Inc.
|
16,562,498 | $61,115,617 | |
| 4 | MAZE |
Maze Therapeutics, Inc.
|
1,388,583 | $41,435,316 | |
| 5 | RLAY |
Relay Therapeutics, Inc.
|
1,410,029 | $26,381,642 | |
| 6 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
This page
|
2,823,126 | $21,512,220 | |
| 7 | BEAM |
Beam Therapeutics Inc.
|
321,604 | $11,037,449 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
241,264 | $10,352,638 |
All Filings in BBOT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,512,220 | 2,823,126 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $25,266,977 | 2,823,126 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $35,345,537 | 2,823,126 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $32,691,799 | 2,823,126 | Shares | Defined | 2025-11-07 | |
| No filing history on record for this holder in this stock. | ||||||